Industry
Healthy, diabetic, and obese people compared on diet and lifestyle using innovative technologies and multi-omics analysis
Servatus are hopeful this study will eventuate into real benefits to sufferers of rheumatoid arthritis
René Kamminga, CEO of OptiBiotix: “OptiXOS is unlike any prebiotic fibre commercially available in Europe today".
BioAro is a biotechnology company redefining healthcare through genetic sequencing, AI development and blockchain technologies.
Funds to be invested to further advance Clinical Microbiomics’ leading microbiome profiling and systems biology platform, and to expand into new offerings and markets
Marco Caspani, Chief Executive Officer at CSL Srl, discussed the challenges and the opportunity of producing anaerobic bacteria during the press conference on The Akkermansia Company.
Michael Oredsson, CEO at The Akkermansia Company, discussed with the new postbiotic supplement containing pastorised Akkermansia muciniphila.
Stijn Oste, Vice president Metagenics, head EMEA, presents the new supplement during the press conference held in Milan (Italy).
Denise Kelly (Investment Advisor at Seventure) discussed the next challenges and opportunities in the field of gut microbiome therapeutics.
Connect directly with the global microbiome partners.
